New curcumin-loaded nanocapsules as a therapeutic alternative in an amnesia model
Authors:
- Karline da Costa RodriguesKRKarline da Costa Rodrigues
- Victor Dos Santos BarbozaVBVictor Dos Santos Barboza
- Sandra Elisa HassSandra Elisa Hass
- Rodrigo de Almeida VaucherRVRodrigo de Almeida Vaucher
- Janice Luehring GiongoJGJanice Luehring Giongo
- Ricardo Frederico SchumacherRSRicardo Frederico Schumacher
- Ethel Antunes WilhelmEthel Antunes Wilhelm
- Cristiane LucheseCLCristiane Luchese
- 14 February 2024
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 39 (4) , 589-609
Abstract
This study aimed to investigate the action of two different formulations of curcumin (Cur)-loaded nanocapsules (Nc) (Eudragit [EUD] and poly (ɛ-caprolactone) [PCL]) in an amnesia mice model. We also investigated the formulations’ effects on scopolamine-induced (SCO) depressive- and anxiety-like comorbidities, the cholinergic system, oxidative parameters, and inflammatory markers. Male Swiss mice were randomly divided into five groups (n = 8): group I (control), group II (Cur PCL Nc 10 mg/kg), group III (Cur EUD Nc 10 mg/kg), group IV (free Cur 10 mg/kg), and group V (SCO). Treatments with Nc or Cur (free) were performed daily or on alternate days. After 30 min of treatment, the animals received the SCO and were subjected to behavioral tests 30 min later (Barnes maze, open-field, object recognition, elevated plus maze, tail suspension tests, and step-down inhibitory avoidance tasks). The animals were then euthanized and tissue was removed for biochemical assays. Our results demonstrated that Cur treatment (Nc or free) protected against SCO-induced amnesia and depressive-like behavior. The ex vivo assays revealed lower acetylcholinesterase (AChE) and catalase (CAT) activity, reduced thiobarbituric species (TBARS), reactive species (RS), and non-protein thiols (NSPH) levels, and reduced interleukin-6 (IL-6) and tumor necrosis factor (TNF) expression. The treatments did not change hepatic markers in the plasma of mice. After treatments on alternate days, Cur Nc had a more significant effect than the free Cur protocol, implying that Cur may have prolonged action in Nc. This finding supports the concept that it is possible to achieve beneficial effects in nanoformulations, and treatment on alternate days differs from the free Cur protocol regarding anti-amnesic effects in mice. Graphical abstractKeywords
All Related Versions
Funding Information
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (PqG 19/2551-0001745-6)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (160674/2020-4)
This publication has 77 references indexed in Scilit:
- Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNFBehavioural Brain Research, 2013
- Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Diphenyl ditelluride impairs short-term memory and alters neurochemical parameters in young ratsPharmacology Biochemistry and Behavior, 2009
- Bioavailability of Curcumin: Problems and PromisesMolecular Pharmaceutics, 2007
- Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative–antioxidative systemsHuman Psychopharmacology: Clinical and Experimental, 2007
- Effects of systemic administration of β-casomorphin-5 on learning and memory in miceEuropean Journal of Pharmacology, 2006
- The cholinergic hypothesis of Alzheimer's disease: a review of progressJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- The open-field test: A critical review.Psychological Bulletin, 1976